SEC Form 4 · accession 0001127602-16-052265
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Richard Reese
Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 2:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 12, 2016 | A | 2,260 | $0.00 | A | 33,383 | D | |
| Common StockF2 | May 12, 2016 | A | 850 | $0.00 | A | 34,233 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 2,260 unvested restricted stock units that vest upon the earlier of 5/12/2017 or the business day prior to the Company's next annual meeting of shareholders.
- F2This grant was made in lieu of cash director services fees for the term commencing May 11, 2016. The restricted stock units vest upon the earlier of 5/12/2017 or the business day prior to the Company's next annual meeting of shareholders.